Shanghai, China · Founded 2013 · Privately Held (backing)
Developer of gene editing and cell engineering platforms intended for genetic and immune-related disorders. BRL Medicine is based in Shanghai, China and was founded in 2013. It has raised $55.6 million.
Last price · $/share
—
Implied valuation
—
Total raised
$55.6M
Last round
—
Cap table — not yet on record
BRL Medicine's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BRL Medicine with a free account
·The complete investor list: 14 names
·Watch BRL Medicine: the Monday email on marks, rounds and moves
